{"id":1036384,"date":"2012-06-20T05:19:51","date_gmt":"2012-06-20T05:19:51","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/the-state-of-the-global-economy-takes-center-stage-during-2012-bio-international-convention-keynote-address.php"},"modified":"2024-08-17T15:55:59","modified_gmt":"2024-08-17T19:55:59","slug":"the-state-of-the-global-economy-takes-center-stage-during-2012-bio-international-convention-keynote-address","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/the-state-of-the-global-economy-takes-center-stage-during-2012-bio-international-convention-keynote-address.php","title":{"rendered":"The State of the Global Economy Takes Center Stage During 2012 BIO International Convention Keynote Address"},"content":{"rendered":"<p><p>      BOSTON--(BUSINESS WIRE)--    <\/p>\n<p>      The       Biotechnology Industry Organization today hosted two      former Secretaries of the U.S. Treasury, Robert E. Rubin and      Henry M. Paulson, Jr., during a luncheon keynote session      where they discussed the current state and future prospects      of the global economy.    <\/p>\n<p>      The event held at the Boston Convention and Exhibition Center      was a part of the       2012 BIO International Convention the worlds largest      biotechnology event, which is expected to attract more than      15,500 attendees from 48 states and 65 countries. BIO      President & CEO Jim Greenwood moderated the discussion,      tackling vital issues such as the present global economic      trials facing the European sovereign debt crisis, the need to      balance austerity and growth, and how such challenges and      public policy reactions will affect biotechnology innovation      and investment in the coming years.    <\/p>\n<p>      Global economic developments impact all facets of the      biotechnology sector, from startups seeking the next funding      round to the largest multinational planning its growth      strategy for the years to come. Small- and medium-sized      biotech companies also continue to face challenges in      accessing the necessary capital required to bring their      innovative cures, breakthrough medicines, cleaner fuels and      more efficient and environmentally friendly agriculture      technologies to market.    <\/p>\n<p>      About BIO    <\/p>\n<p>      BIO represents more than 1,100 biotechnology companies,      academic institutions, state biotechnology centers and      related organizations across the United States and in more      than 30 other nations. BIO members are involved in the      research and development of innovative healthcare,      agricultural, industrial and environmental biotechnology      products. BIO also produces the BIO International Convention,      the worlds largest gathering of the biotechnology industry,      along with industry-leading investor and partnering meetings      held around the world. BIO produces       BIOtechNOW, an online portal and monthly newsletter      chronicling innovations transforming our world.       Subscribe to BIOtechNOW.    <\/p>\n<\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/state-global-economy-takes-center-224900529.html;_ylt=A2KJjahfXeFPmmYAU43_wgt.\" title=\"The State of the Global Economy Takes Center Stage During 2012 BIO International Convention Keynote Address\" rel=\"noopener\">The State of the Global Economy Takes Center Stage During 2012 BIO International Convention Keynote Address<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BOSTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization today hosted two former Secretaries of the U.S. Treasury, Robert E.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/the-state-of-the-global-economy-takes-center-stage-during-2012-bio-international-convention-keynote-address.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036384","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036384"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036384"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036384\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}